C. Rocamboli Stephen's most recent trade in Esperion Therapeutics Inc. was a trade of 44,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 33,000 | 69,261 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 3,165 | 39,165 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 3,165 | 3,165 | - | - | Stock Options (Right to Buy) | |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 23,000 | 36,261 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 4,667 | 4,667 | - | - | Restricted stock units | |
| Tff Pharmaceuticals Inc | C. Rocamboli Stephen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 52,858 | 52,858 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Stephen C. Rocamboli | Director | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 15 Aug 2023 | 20,000 | 36,000 (0%) | 0% | 0.3 | 5,000 | Common Stock |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 21,000 | 21,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,150 | 13,261 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 10 May 2023 | 8,111 | 8,111 (0%) | 0% | 1.5 | 12,126 | Common Stock |
| Tff Pharmaceuticals Inc | Stephen C. Rocamboli | Director | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 10 Mar 2023 | 13,000 | 16,000 (0%) | 0% | 0.8 | 10,433 | Common Stock |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 1,589 | 1,589 | - | - | Stock Option (right to buy) | |
| Tff Pharmaceuticals Inc | Stephen C. Rocamboli | Director | Purchase of securities on an exchange or from another person at price $ 4.54 per share. | 16 May 2022 | 3,000 | 18,722 (0%) | 0% | 4.5 | 13,620 | Common Stock |